Concepedia

Author

Karim Vermaelen

Ghent University Hospital

Also Known As

K. V. Vermaelen, K. Vermaelen, Karim V Vermaelen, Karim Vermaelen, Vermaelen, Karim

18

Publications

1.9K

Citations

11

H-Index

32

Concepts

All Affiliations

Ghent University HospitalGhent UniversityCancer Research Institute GhentInserm
KV

About

Karim Vermaelen is an author at Ghent University Hospital specializing in medicine, tumor microenvironment, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

1.3K

2

Cell Biology

2

2

1.2K

3

Natural Sciences

1

1

923

4

Immunology

1

1

242

5

Molecular Biology

1

1

923

Karim Vermaelen

×

7

Publications

1.5K

Citations

7

H-Index

YearCitations

The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling

Jan Van Deun, Pieter Mestdagh, Raija Sormunen,

Journal of Extracellular Vesicles

2014

923

Accurate and simple discrimination of mouse pulmonary dendritic cell and macrophage populations by flow cytometry: Methodology and new insights

Karim Vermaelen, Romain Pauwels

Cytometry Part A

2004

242

Chemokine Receptor CCR2 but Not CCR5 or CCR6 Mediates the Increase in Pulmonary Dendritic Cells during Allergic Airway Inflammation

Lander Robays, Tania Maes, Serge Lebecque,

The Journal of Immunology

2007

119

Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients

Reinhart Speeckaert, Karim Vermaelen, Nanja van Geel,

European Journal of Cancer

2011

109

First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817

Neal Ready, Clarisse Audigier-Valette, Jonathan W. Goldman,

Journal for ImmunoTherapy of Cancer

2023

67

Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever

Hanne Van Gorp, Linyan Huang, Pedro Saavedra,

Annals of the Rheumatic Diseases

2020

49

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial

Katrien De Wolf, Sylvie Rottey, Karim Vermaelen,

Radiation Oncology

2017

35

Page 1